Key Financial Data Of Group

株式会社ＰＲＩＳＭ　ＢｉｏＬａｂ - Filing #7333205

Concept	As at 2024-04-30	2022-10-01 to 2023-09-30	As at 2023-09-30	2021-10-01 to 2022-09-30	As at 2022-09-30	2020-10-01 to 2021-09-30	As at 2021-09-30	2019-10-01 to 2020-09-30	As at 2020-09-30	2018-10-01 to 2019-09-30	As at 2019-09-30
Key financial data of group
Business results of group
Net sales	—	112,926,000 JPY	—	554,396,000 JPY	—	58,801,000 JPY	—	206,205,000 JPY	—	106,000,000 JPY	—
Ordinary profit (loss)	—	-497,550,000 JPY	—	78,666,000 JPY	—	-153,707,000 JPY	—	-139,998,000 JPY	—	-144,783,000 JPY	—
Net assets	—	—	1,148,015,000 JPY	—	1,674,930,000 JPY	—	1,092,912,000 JPY	—	-51,098,000 JPY	—	91,601,000 JPY
Total assets	—	—	1,211,426,000 JPY	—	1,740,156,000 JPY	—	1,509,715,000 JPY	—	400,986,000 JPY	—	563,381,000 JPY
Net assets per share	—	—	-34.50	—	-15.41	—	-6,231.85	—	-6,711.33	—	-5,241.37
Basic earnings (loss) per share	—	-19.09	—	2.67	—	-1,556.87	—	-1,469.95	—	-1,575.61	—
Diluted earnings per share	—		—		—		—		—		—
Equity-to-asset ratio	—	—	0.947 xbrli:pure	—	0.962 xbrli:pure	—	0.724 xbrli:pure	—	xbrli:pure	—	0.162 xbrli:pure
Rate of return on equity	—	xbrli:pure	—	0.053 xbrli:pure	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—
Price-earnings ratio	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—
Net cash provided by (used in) operating activities	—	-513,811,000 JPY	—	102,962,000 JPY	—	JPY	—	JPY	—	JPY	—
Net cash provided by (used in) investing activities	—	-40,377,000 JPY	—	-7,874,000 JPY	—	JPY	—	JPY	—	JPY	—
Net cash provided by (used in) financing activities	—	JPY	—	110,872,000 JPY	—	JPY	—	JPY	—	JPY	—
Cash and cash equivalents	—	—	1,133,943,000 JPY	—	1,687,993,000 JPY	—	JPY	—	JPY	—	JPY
Number of employees	22 xbrli:pure	—	17 xbrli:pure	—	12 xbrli:pure	—	7 xbrli:pure	—	6 xbrli:pure	—	8 xbrli:pure
Average number of temporary employees	8 xbrli:pure	—	5 xbrli:pure	—	2 xbrli:pure	—	3 xbrli:pure	—	5 xbrli:pure	—	5 xbrli:pure